Los Angeles – September 11, 2026 -- Schall, Brown & Schwartz LLP (SBS) has filed a class action lawsuit against Datavault AI Inc. (NASDAQ: DVLT), alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The suit covers investors who purchased DVLT shares between September 4, 2024 and October 30, 2025.

Los Angeles – September 11, 2026 -- Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI) have until September 21, 2026, to seek lead plaintiff status in a securities fraud class action covering purchases made between February 29, 2024, and May 1, 2026.

Los Angeles – September 10, 2026 -- Schall, Brown & Schwartz LLP (SBS) has issued a reminder to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of a securities class action lawsuit alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lead plaintiff deadline is set for September 28, 2026.

Los Angeles -- Shareholders of Pentair plc (NYSE: PNR) have until October 2, 2026 to seek lead plaintiff status in a securities fraud class action filed against the water treatment and pool equipment manufacturer, according to Schall, Brown & Schwartz LLP (SBS).

Los Angeles – September 10, 2026 -- Schall, Brown & Schwartz LLP has filed a class action lawsuit against Blaize Holdings, Inc. (NASDAQ: BZAI), alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lawsuit covers investors who purchased BZAI shares between July 18, 2025 and April 28, 2026, with a lead plaintiff filing deadline set for October 5, 2026.

Los Angeles – – September 10, 2026 -- Schall, Brown & Schwartz LLP has filed a federal securities class action against Beta Bionics, Inc. (NASDAQ: BBNX), alleging the company misled investors about FDA findings tied to its iLet Bionic Pancreas insulin pump. The case, Holtzman v. Beta Bionics, Inc. et al., No. 2:26-cv-09999, is pending in the U.S. District Court for the Central District of California.